Birgit Debrabant

Medicine & Life Sciences

1. Aged, 80 and over 28%
2. Alemtuzumab 24%
3. Benchmarking 19%
4. Biomarkers 57%
5. Biomedical Research 17%
6. Cardiogenic Shock 20%
7. Denmark 51%
8. DNA Methylation 45%
9. DNA Repair 19%
10. Drainage 48%
11. Elderly 25%
12. Epigenome 29%
13. Equipment and Supplies 22%
14. Exercise 23%
15. Fibrinolysis 19%
16. Genes 52%
17. Genome 21%
18. Genome-Wide Association Study 77%
19. Guidelines 31%
20. Hand Strength 26%
21. Hematoma, Subdural, Chronic 100%
22. Hepatitis C 18%
23. Intelligence 18%
24. Ischemic Postconditioning 27%
25. Ischemic Preconditioning 22%
26. Longevity 74%
27. Meningeal Arteries 27%
28. Meta-Analysis 80%
29. Metabolomics 19%
30. methylallyl trisulfide 24%
31. Monozygotic Twins 26%
32. Mortality 40%
33. Multiple Sclerosis 31%
34. Muscle Strength 18%
35. Optic Neuritis 22%
36. P-Selectin 21%
37. Population 30%
38. Prospective Studies 22%
39. Proteome 25%
40. Randomized Controlled Trials 23%
41. Recurrence 34%
42. Sample Size 20%
43. Secondary Headache Disorders 27%
44. Selenium 19%
45. Single Nucleotide Polymorphism 33%
46. Statistical Models 26%
47. Systematic Reviews 26%
48. Tensile Strength 20%
49. Traffic Accidents 20%
50. Twins 40%